Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study).
AIDS Res Ther
; 16(1): 34, 2019 11 15.
Article
in En
| MEDLINE
| ID: mdl-31729999
Key words
Full text:
1
Collection:
01-internacional
Health context:
2_ODS3
/
3_ND
/
4_TD
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Pneumonia, Pneumocystis
/
HIV Infections
/
Toxoplasmosis
/
Acquired Immunodeficiency Syndrome
/
Antiretroviral Therapy, Highly Active
/
Anti-Retroviral Agents
Type of study:
Clinical_trials
/
Guideline
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
AIDS Res Ther
Year:
2019
Document type:
Article